Citius Oncology Inc. (CTOR) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Citius Oncology Inc.

    NASDAQ: CTOR · Real-Time Price · USD
    1.89
    0.01 (0.53%)
    At close: Oct 03, 2025, 3:59 PM
    1.97
    4.23%
    Pre-market: Oct 06, 2025, 05:34 AM EDT

    Citius Oncology Balance Sheet Statement

    Financials in USD. Fiscal year is October - September.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022
    Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022
    Cash & Equivalents
    		 112.00 26.52K 289.18K
    Short-Term Investments
    		 n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a
    Other Long-Term Assets
    		 n/a n/a n/a
    Receivables
    		 n/a n/a n/a
    Inventory
    		 8.27M n/a n/a
    Other Current Assets
    		 n/a n/a n/a
    Total Current Assets
    		 10.97M 7.73M 2.69M
    Property-Plant & Equipment
    		 n/a n/a n/a
    Goodwill & Intangibles
    		 73.4M 40M 40M
    Total Long-Term Assets
    		 73.4M 40M 40M
    Total Assets
    		 84.37M 47.73M 42.69M
    Account Payables
    		 3.71M 1.29M 92.31K
    Deferred Revenue
    		 n/a n/a n/a
    Short-Term Debt
    		 n/a n/a n/a
    Other Current Liabilities
    		 -588.8K n/a n/a
    Total Current Liabilities
    		 32.7M 21.05M 5.85M
    Long-Term Debt
    		 3.8M n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a
    Total Long-Term Liabilities
    		 5.53M 1.15M 576K
    Total Liabilities
    		 38.23M 22.2M 6.42M
    Total Debt
    		 3.8M n/a n/a
    Book Value
    		 46.14M 25.54M 36.27M
    Book Value Per Share
    		 0.64 0.29 0.40
    Common Stock
    		 7.16K 6.75K 6.75K
    Retained Earnings
    		 -39.28M -18.13M -5.43M
    Comprehensive Income
    		 n/a n/a n/a
    Shareholders Equity
    		 46.14M 25.54M 36.27M
    Total Investments
    		 n/a 70.63M 67.81M

    Add to Watchlist